Caffeine and multiple sclerosis: does coffee really fight inflammation, fatigue and disease progression? (2024–2025 evidence)

July 13, 2026

A viral infographic claims caffeine helps fight inflammation in MS. We checked the actual studies — a 2024 systematic review, a 2025 meta-analysis of 900,000+ people, a 2025 randomised trial on fatigue, and mechanistic work on the NLRP3 inflammasome. Here is what coffee really does, what it does not do, and how much is safe if you live with MS.

Why we are writing this

I keep returning to this subject because a useful answer should be precise without losing sight of everyday life. An infographic by MyMSTeam has been circulating widely: "Caffeine can help fight inflammation" in multiple sclerosis. The post is not wrong — but it is a one-line summary of a nuanced body of research. This article goes to the actual studies (a 2024 systematic review, a 2025 meta-analysis of over 900,000 people, a 2025 randomised controlled trial on MS-related fatigue and mechanistic work on the NLRP3 inflammasome) and separates what coffee really does for people with MS from what the internet claims.

What is caffeine, really

Caffeine (1,3,7-trimethylxanthine) is the most consumed psychoactive substance in the world. It crosses the blood-brain barrier easily and blocks adenosine A1 and A2A receptors in the brain. That single mechanism explains the alertness, the reduced fatigue, the mild pain relief — and, as recent MS research suggests, part of its anti-inflammatory and possibly neuroprotective effect.

What the studies actually show

Coffee lowers the risk of ever developing MS

A large systematic review and meta-analysis published in *Autoimmunity Reviews* (Amirnia et al., 2025) pooled data from studies covering more than 900,000 participants. People with the highest coffee intake had a statistically significant lower risk of MS than non-drinkers ([DOI: 10.1016/j.autrev.2025.103822](https://doi.org/10.1016/j.autrev.2025.103822)). An earlier landmark 2016 paper in the *Journal of Neurology, Neurosurgery & Psychiatry* found that drinking ≥900 ml of coffee per day (roughly 4–6 cups) was linked to about ~30% lower MS risk in two independent Swedish and US cohorts ([JNNP 2016](https://jnnp.bmj.com/content/87/5/454)).

Important caveat: a 2020 UK Biobank Mendelian randomisation study using genetic variants for coffee intake found no causal effect on MS risk. In other words, coffee drinkers may share other lifestyle factors that protect them, and coffee itself may not be the reason. The observational signal is real, but "coffee prevents MS" is a stronger claim than the data supports.

Caffeine has anti-inflammatory effects in MS models

The MyMSTeam claim comes from laboratory and animal research. The best-known paper (Wang et al., *Journal of Molecular Neuroscience*, 2021) showed that in EAE — the mouse model of MS — caffeine inhibits the NLRP3 inflammasome through autophagy, reducing microglial neuroinflammation and easing the disease course ([DOI: 10.1007/s12031-021-01894-8](https://doi.org/10.1007/s12031-021-01894-8)). The NLRP3 inflammasome is one of the central engines of CNS inflammation, so blocking it matters mechanistically. Green tea polyphenols (mainly EGCG) act on similar inflammatory pathways, which is why the infographic mentions tea alongside coffee.

What this does not prove: that drinking coffee will silence inflammation in a human brain the way it does in a mouse fed a chemical demyelinating agent. Human MS is more complex and no clinical trial has yet shown that coffee changes MRI lesion activity or annualised relapse rate.

Caffeine and MS-related fatigue

Fatigue is the single most disabling symptom for many people with MS ([our fatigue guide](/en/blog/fatigue-ms-therapies-strategies)). A 2025 randomised, double-blind, placebo-controlled trial ([PubMed](https://pubmed.ncbi.nlm.nih.gov/41406935/)) tested caffeine supplementation against placebo in people with MS. Caffeine produced a measurable improvement in fatigue scores compared with placebo, without serious adverse effects at the doses studied. This is the strongest human evidence to date that caffeine has a real symptomatic benefit in MS — but the effect is modest and does not replace [DMT therapy](/en/blog/all-ms-dmt-drugs-2026-complete-guide) or targeted fatigue treatments.

Caffeine, balance and mobility

A 2024 single-arm pilot published in *PLOS ONE* ([PMC10863863](https://pmc.ncbi.nlm.nih.gov/articles/PMC10863863/)) suggested that a single caffeine dose can transiently improve balance and mobility measures in people with MS. Pilot, uncontrolled — hypothesis-generating only — but it aligns with what patients often report anecdotally.

A 2024 comprehensive systematic review

Salekzamani et al. published a systematic review of caffeine effects in MS patients in *Journal of Evidence-Based Integrative Medicine* (2024) ([Sage Journals](https://journals.sagepub.com/doi/10.1177/2515690X241293114)). Across the included studies, moderate caffeine intake was associated with reduced fatigue and no signal of harm on MS activity. The authors explicitly noted that the evidence base is still small and calls for larger trials.

What caffeine does NOT do

- It does not cure MS. No study shows caffeine slows disability progression or reduces new MRI lesions.

- It does not replace disease-modifying therapy. Coffee is not a substitute for [Ocrevus](/en/blog/ocrevus-ocrelizumab-complete-2026-guide-works-efficacy-safety-access-ms), [Kesimpta](/en/blog/kesimpta-ofatumumab-complete-2026-guide-works-efficacy-self-injection-ms), [Tysabri](/en/blog/tysabri-natalizumab-complete-2026-guide-works-affirm-efficacy-pml-risk-ms), [Mavenclad](/en/blog/mavenclad-cladribine-complete-2026-guide-short-oral-course-long-term-ms), [Tecfidera](/en/blog/tecfidera-dimethyl-fumarate-complete-2026-guide-works-define-confirm-ms) or [Copaxone](/en/blog/copaxone-glatiramer-acetate-complete-2026-guide-works-gala-efficacy-ms).

- It does not universally reduce inflammation. Mechanistic studies in animals show anti-inflammatory effects; human MS trials of that specific endpoint do not exist yet.

- It does not reverse existing damage. Remyelination research (see our post on [ATDR/Retsat](/en/blog/a-newly-discovered-molecule-atdr-helps-repair-myelin-restore-nerve-ms)) is a separate field.

How much coffee is reasonable if you have MS?

- Up to 400 mg of caffeine per day is considered safe for most healthy adults by the European Food Safety Authority (EFSA) and FDA — that is roughly 3–4 espressos, 2–3 large brewed coffees, or 4–5 cups of green tea.

- Timing matters. Caffeine has a half-life of 5–7 hours (longer if you take oral contraceptives or have liver disease). Coffee after ~2 p.m. can worsen the sleep problems that already amplify MS fatigue and cognition issues.

- Bladder overactivity. Caffeine is a diuretic and a bladder irritant. If you have [MS-related overactive bladder or urgency](/en/blog/bladder-dysfunction-ms-overactive-retention), reducing caffeine (or switching to decaf) often produces a noticeable improvement.

- Spasticity, tremor and anxiety. Very high doses (>500 mg/day) can worsen [tremor](/en/blog/ms-tremor-hands-legs-stop), [spasticity](/en/blog/spasticity-ms-happens-treat) and anxiety in some people. Titrate to what you tolerate.

- Heat sensitivity. Hot coffee can transiently trigger [Uhthoff phenomenon](/en/blog/uhthoff-phenomenon-surviving-heat-ms) in heat-sensitive patients. Iced coffee is a simple workaround.

- Interactions. Caffeine interacts with several DMTs and symptomatic drugs (tizanidine, fluvoxamine, some antibiotics). Ask your neurologist or pharmacist.

For readers in Serbia and the region

Coffee culture is central to Balkan life, and people with MS often ask whether they should quit. Based on the evidence above: there is no reason to quit moderate coffee consumption because of MS — in fact, moderate intake may modestly reduce fatigue. The practical priorities remain: stay on your DMT, work with your [MS centre](/en/blog/multiple-sclerosis-clinics-centres-serbia-public-hospitals-private), sleep well, exercise, keep vitamin D adequate ([our vitamin D guide](/en/blog/vitamin-d-ms-science-says)), and stop smoking (which is the strongest lifestyle factor that *worsens* MS).

The MyMSTeam infographic is a fair, if simplified, summary of a growing body of research. Caffeine does have plausible anti-inflammatory activity (proven in animal MS models), a modest measurable effect on fatigue in randomised human trials, and an observational association with lower MS risk in large populations. But it is not a treatment, does not replace DMT, and is not universally harmless — bladder, sleep, tremor and heat sensitivity are real caveats. Enjoy your coffee if you enjoy it. Do not start drinking it for MS.

Sources

- Amirnia M et al. *Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis.* Autoimmunity Reviews, 2025. [DOI](https://doi.org/10.1016/j.autrev.2025.103822)

- Salekzamani S et al. *The Effects of Coffee/Caffeine in Patients with Multiple Sclerosis: A Systematic Review.* J Evid-Based Integrative Med, 2024. [Sage](https://journals.sagepub.com/doi/10.1177/2515690X241293114)

- Wang H et al. *Caffeine Inhibits Activation of the NLRP3 Inflammasome via Autophagy in EAE.* J Mol Neurosci, 2021. [PubMed](https://pubmed.ncbi.nlm.nih.gov/34478049/)

- Hedström AK et al. *High consumption of coffee is associated with decreased multiple sclerosis risk.* JNNP, 2016. [BMJ](https://jnnp.bmj.com/content/87/5/454)

- *Efficacy of caffeine supplementation on fatigue in MS: RCT.* 2025. [PubMed](https://pubmed.ncbi.nlm.nih.gov/41406935/)

- *Caffeine ingestion on balance and mobility in MS: pilot trial.* PLOS ONE, 2024. [PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC10863863/)